These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 4402775

  • 1. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE, Corrodi H, Fuxe K.
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract] [Full Text] [Related]

  • 2. Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.
    Nybäck H.
    Acta Pharmacol Toxicol (Copenh); 1971 Mar; 30(5):372-84. PubMed ID: 4401187
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR, Grant LD, Breese GR.
    Psychopharmacologia; 1973 Jul 17; 31(2):95-109. PubMed ID: 4722209
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO, Hamberger B, Jonsson G.
    J Neurochem; 1971 Dec 17; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract] [Full Text] [Related]

  • 8. Role of brain noradrenaline in morphine-induced stereotyped behaviour.
    Ayhan IH, Randrup A.
    Psychopharmacologia; 1972 Dec 17; 27(3):203-12. PubMed ID: 4674514
    [No Abstract] [Full Text] [Related]

  • 9. Minor tranquillizers, stress and central catecholamine neurons.
    Corrodi H, Fuxe K, Lidbrink P, Olson L.
    Brain Res; 1971 Jun 04; 29(1):1-16. PubMed ID: 5564261
    [No Abstract] [Full Text] [Related]

  • 10. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.
    Lassen JB.
    Psychopharmacologia; 1974 Jun 04; 37(4):331-40. PubMed ID: 4136728
    [No Abstract] [Full Text] [Related]

  • 11. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE, Fuxe K.
    Br J Pharmacol; 1971 Dec 04; 43(4):747-56. PubMed ID: 4339882
    [Abstract] [Full Text] [Related]

  • 12. Effect of neuroleptics on endogenous norepinephrine in rat brain.
    Bartholini G, Keller HH, Pletscher A.
    Neuropharmacology; 1973 Aug 04; 12(8):751-6. PubMed ID: 4746440
    [No Abstract] [Full Text] [Related]

  • 13. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
    Hasselager E, Rolinski Z, Randrup A.
    Psychopharmacologia; 1972 Aug 04; 24(4):485-95. PubMed ID: 5064290
    [No Abstract] [Full Text] [Related]

  • 14. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K, Nyström M, Tovi M, Smith R, Ogren SO.
    J Psychiatr Res; 1974 Aug 04; 11():151-61. PubMed ID: 4156786
    [No Abstract] [Full Text] [Related]

  • 15. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH, Davis WM.
    J Pharmacol Exp Ther; 1977 Jul 04; 202(1):182-91. PubMed ID: 17725
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of catecholamine synthesis during ontogenic development.
    Kellogg C, Lundborg P.
    Brain Res; 1973 Oct 26; 61():321-9. PubMed ID: 4149305
    [No Abstract] [Full Text] [Related]

  • 17. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z, Scheel-Krüger J.
    Acta Pharmacol Toxicol (Copenh); 1973 Oct 26; 33(5):385-99. PubMed ID: 4149038
    [No Abstract] [Full Text] [Related]

  • 18. Differential effects on mouse brain catecholamine turnover of chlorpromazine, trifluoperazine and closely-related non-tranquillizing analogues.
    Green AL.
    J Pharm Pharmacol; 1973 Mar 26; 25(3):267-9. PubMed ID: 4146333
    [No Abstract] [Full Text] [Related]

  • 19. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S.
    Brain Res; 1974 Mar 29; 69(1):57-65. PubMed ID: 4150408
    [No Abstract] [Full Text] [Related]

  • 20. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA, Shore PA.
    J Pharm Pharmacol; 1978 Jul 29; 30(7):464-6. PubMed ID: 27622
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.